Literature DB >> 14672554

The enigmatic role of angiopoietin-1 in tumor angiogenesis.

Linda J Metheny-Barlow1, Lu Yuan Li.   

Abstract

A tumor vasculature is highly unstable and immature, characterized by a high proliferation rate of endothelial cells, hyper-permeability, and chaotic blood flow. The dysfunctional vasculature gives rise to continual plasma leakage and hypoxia in the tumor, resulting in constant on-sets of inflammation and angiogenesis. Tumors are thus likened to wounds that will not heal. The lack of functional mural cells, including pericytes and vascular smooth muscle cells, in tumor vascular structure contributes significantly to the abnormality of tumor vessels. Angiopoietin-1 (Ang1) is a physiological angiogenesis promoter during embryonic development. The function of Ang1 is essential to endothelial cell survival, vascular branching, and pericyte recruitment. However, an increasing amount of experimental data suggest that Ang1-stimulated association of mural cells with endothelial cells lead to stabilization of newly formed blood vessels. This in turn may limit the otherwise continuous angiogenesis in the tumor, and consequently give rise to inhibition of tumor growth. We discuss the enigmatic role of Ang1 in tumor angiogenesis in this review.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14672554     DOI: 10.1038/sj.cr.7290176

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  28 in total

1.  Endothelial progenitor cells homing and renal repair in experimental renovascular disease.

Authors:  Alejandro R Chade; Xiang-Yang Zhu; James D Krier; Kyra L Jordan; Stephen C Textor; Joseph P Grande; Amir Lerman; Lilach O Lerman
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

2.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

3.  Astrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment.

Authors:  Ulla Milbreta; Ysander von Boxberg; Philippe Mailly; Fatiha Nothias; Sylvia Soares
Journal:  J Neurotrauma       Date:  2014-03-31       Impact factor: 5.269

4.  Angiopoietin and vascular endothelial growth factor expression in colorectal disease models.

Authors:  Wei-Xin Liu; Shou-Zhi Gu; Shen Zhang; Yi Ren; Li-Xuan Sang; Cong Dai
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

5.  The TRPC5 channel regulates angiogenesis and promotes recovery from ischemic injury in mice.

Authors:  Yifei Zhu; Mengru Gao; Tingting Zhou; Mingxu Xie; Aiqin Mao; Lei Feng; Xiaoqiang Yao; Wing Tak Wong; Xin Ma
Journal:  J Biol Chem       Date:  2018-11-09       Impact factor: 5.157

6.  Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer.

Authors:  K Danza; B Pilato; R Lacalamita; T Addati; F Giotta; A Bruno; A Paradiso; S Tommasi
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

Review 7.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Authors:  Dai Fukumura; Jonas Kloepper; Zohreh Amoozgar; Dan G Duda; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

8.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Authors:  Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

9.  Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice.

Authors:  Tatsuma Okazaki; Amy Ni; Peter Baluk; Oluwasheyi A Ayeni; Jennifer Kearley; Anthony J Coyle; Alison Humbles; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

Review 10.  New molecular targets in angiogenic vessels of glioblastoma tumours.

Authors:  Joshua C Anderson; Braden C McFarland; Candece L Gladson
Journal:  Expert Rev Mol Med       Date:  2008-08-07       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.